Label: DERMAN ANTIFUNGAL CREAM- tolnaftate cream
- NDC Code(s): 81929-004-01, 81929-004-02
- Packager: Taisho Pharmaceutical California Inc.
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated November 10, 2023
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active ingredient
- Uses
- Warnings
-
Directions
- wash affected area and dry thoroughly
- apply a thin layer over affected area twice daily (morning and night) or as directed by a doctor
- supervise children in the use of this product
- for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily
- for athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks
- if condition persists longer, consult a doctor
- this product is not effective on the scalp or nails
- Other information
- Inactive ingredients
- Package Labeling:25g
- Package Labeling:50g
-
INGREDIENTS AND APPEARANCE
DERMAN ANTIFUNGAL CREAM
tolnaftate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:81929-004 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE 10 mg in 1 g Inactive Ingredients Ingredient Name Strength CETETH-20 (UNII: I835H2IHHX) CETYL ALCOHOL (UNII: 936JST6JCN) CHLOROCRESOL (UNII: 36W53O7109) MINERAL OIL (UNII: T5L8T28FGP) SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW) PETROLATUM (UNII: 4T6H12BN9U) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) STEARYL ALCOHOL (UNII: 2KR89I4H1Y) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:81929-004-02 1 in 1 CARTON 07/01/2022 1 25 g in 1 TUBE; Type 0: Not a Combination Product 2 NDC:81929-004-01 1 in 1 CARTON 07/01/2022 2 50 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 07/01/2022 Labeler - Taisho Pharmaceutical California Inc. (603827635)